Centene, a multinational healthcare enterprise, agreed to acquire Apixio, a healthcare analytics company offering artificial intelligence technology solutions. Financial terms were not disclosed. The transaction is subject to regulatory approvals and is expected to close by the end of 2020. "Centene is committed to accelerating innovation, modernization and digitization across the enterprise and solidify its position as a technology company focused on healthcare. Apixio's capabilities are closely aligned with our plans to digitize the administration of healthcare and to leverage comprehensive data to help improve the lives of our members. Apixio's technology will complement existing data analytics products including Interpreta, creating a differentiated platform to broaden support for value-based healthcare payment and delivery with actionable intelligence," Michael F. Neidorff, Centene Chairman, President and Chief Executive Officer.